Previous Close
$10.52
Day Range
$0 - $0
Previous Day Range
$10.46 - $11.47
Market Cap
$392.5 million USD
Day Vol.
0
Previous Day Vol.
1.5 million
Currency
USD
Primary Exchange
Nasdaq
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug ...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view